EU Project Findings To ‘Instil Confidence’ In Using Patient Preference Studies
The European Medicines Agency’s endorsement of a framework that explains how medical device and drug sponsors can use patient preference studies to answer their research questions could help increase confidence in the conduct and acceptability of such studies.
You may also be interested in...
The EMA is inviting feedback on its plans to ratify, with some caveats, a new framework on how to use patient preferences as input in medical product decision-making. The framework was developed under the EU’s public-private Innovative Medicines Initiative.
The Health Research Authority has developed UK-wide Quality Standards and Design and Review Principles to improve the information given to people who are invited to take part in research. Their use will become mandatory in December.
Revisions to the updated EU guideline on transitioning multinational trials to the Clinical Trials Regulation are said to be “solution oriented.”